Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting.

Jegerlehner, Sabrina; Suter-Riniker, Franziska; Jent, Philipp; Bittel, Pascal; Nagler, Michael (2022). Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting. International journal of infectious diseases, 119, pp. 38-40. Elsevier 10.1016/j.ijid.2022.03.037

[img]
Preview
Text
1-s2.0-S120197122200176X-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (986kB) | Preview

BACKGROUND

SARS-CoV-2 antigen tests with saliva facilitate examination in settings that lack trained personnel. However, little is known on the diagnostic accuracy in real-life clinical settings. Therefore, we studied the diagnostic accuracy of a saliva antigen test to diagnose SARS-CoV-2 infection in a primary/ secondary care testing facility.

METHODS

Individuals presented at a COVID-19 testing facility affiliated with a Swiss University Hospital were prospectively recruited (n=377). Saliva specimen was obtained, and the PCL Inc. COVID19 Gold antigen test was conducted in parallel with two real-time PCR.

RESULTS

RT-PCR was positive in 53 individuals, corresponding to a prevalence of 14.1% (missing material in one individual). The PCL saliva antigen test was positive in 22 individuals (5.8%), and negative in 354 (93.9%). The sensitivity of the saliva antigen test was 30.2% (95% confidence interval, CI, 18.3 to 44.3), both overall and in symptomatic individiduals. The specificity was 98.1% (96.0, 99.3).

CONCLUSIONS

The diagnostic accuracy of a SARS-CoV-2 saliva antigen test in a primary/ secondary care testing facility was remarkably lower compared to the manufacturers' specifications. Keywords Infections/*epidemiology/transmission; severe acute respiratory syndrome coronavirus 2 [Supplementary Concept]; COVID-19 diagnostic testing [Supplementary Concept] Background.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Clinical Microbiology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center

UniBE Contributor:

Jegerlehner, Sabrina, Suter, Franziska Marta, Jent, Philipp, Bittel, Pascal, Nagler, Michael

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

1201-9712

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

04 Apr 2022 11:15

Last Modified:

05 Dec 2022 16:18

Publisher DOI:

10.1016/j.ijid.2022.03.037

PubMed ID:

35364282

BORIS DOI:

10.48350/168939

URI:

https://boris.unibe.ch/id/eprint/168939

Actions (login required)

Edit item Edit item
Provide Feedback